RE
Ronen Elad
CEO & Chairman
Chairman
born 1964comp · ₪500,000
LOADING SNAPSHOT
Fetching the books…
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the production, supply, and marketing of cannabis-based products for medical use in Israel. The company offers cannabis-based products in form of inflorescences, medical cannabis oils based on medical cannabis strains, and based on cannabis strains.
For commercial pharma: watch patent cliffs and competition. For pre-revenue biotech: cash runway and trial readouts.
1 high-severity red flag present. Treat as no-touch unless you have a specific contrarian thesis.
| Period | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2021-12-31 | — | — | — | — | — |
| 2022-12-31 | ₪49.30M | ₪2.43M | ₪-26.67M | ₪-48.23M | -97.8% |
| 2023-12-31 | ₪44.23M | ₪-1.76M | ₪-28.47M | ₪-88.89M | -201.0% |
| 2024-12-31 | ₪34.95M | ₪-1.22M | ₪-14.67M | ₪-40.10M | -114.7% |
| 2025-12-31 | ₪9.10M | ₪880.00K | ₪-9.59M | ₪-15.85M | -174.2% |
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the production, supply, and marketing of cannabis-based products for medical use in Israel. The company offers cannabis-based products in form of inflorescences, medical cannabis oils based on medical cannabis strains, and based on cannabis strains. It also sells medical cannabis products for the treatment and relief of symptoms for various of medical indications. Tikun Olam-Cannbit Pharmaceuticals Ltd was incorporated in 1995 and is based in Nof HaGalil, Israel.